Gastroenterology

Vonanavy

  • Vonanavy
  • Active Ingredient: Vonoprazan 20 mg
  • Product Overview
  • Vonanavy contains Vonoprazan, a novel potassium-competitive acid blocker (P-CAB) used in the treatment of acid-related gastrointestinal disorders.
  • Unlike traditional proton pump inhibitors, Vonoprazan provides rapid and sustained acid suppression, making it effective in managing conditions such as gastroesophageal reflux disease (GERD) and gastric ulcers.
  • Indications
  • Vonanavy may be prescribed for:
  • Gastroesophageal reflux disease (GERD)
  • Gastric ulcers
  • Duodenal ulcers
  • Helicobacter pylori eradication regimens
In Stock
Clinical Grade

Product Description

  • Vonanavy
  • Active Ingredient: Vonoprazan 20 mg
  • Product Overview
  • Vonanavy contains Vonoprazan, a novel potassium-competitive acid blocker (P-CAB) used in the treatment of acid-related gastrointestinal disorders.
  • Unlike traditional proton pump inhibitors, Vonoprazan provides rapid and sustained acid suppression, making it effective in managing conditions such as gastroesophageal reflux disease (GERD) and gastric ulcers.
  • Indications
  • Vonanavy may be prescribed for:
  • Gastroesophageal reflux disease (GERD)
  • Gastric ulcers
  • Duodenal ulcers
  • Helicobacter pylori eradication regimens